Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-news-1/ccny-researchers-demonstrate-effectiveness-of-contrast-agent-cytate-in-detectcing-prostate-cancer-22847-1/) was not found.

Search medicine news 1 ccny researchers demonstrate effectiveness of contrast agent cytate in detectcing prostate cancer 22847 1 at Google

Search medicine news 1 ccny researchers demonstrate effectiveness of contrast agent cytate in detectcing prostate cancer 22847 1 at Yahoo

Search medicine news 1 ccny researchers demonstrate effectiveness of contrast agent cytate in detectcing prostate cancer 22847 1 at Msn

Google
 
Breaking Biology News(10 mins):The impact of the diffusion of maize to the Southwestern United States 2ADA releases updated position paper on nutrient supplementation 2UAB bone center director wins distinguished service award from clinical pathology society 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 1Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 2Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 3Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 4Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 5Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC 305 13415 6Argonne to showcase science and technology at community open house 9498 1Argonne to showcase science and technology at community open house 9498 2Cryo Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 53840 1Cryo Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 53840 2Cryo Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 53840 3Cryo Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum 53840 4
Breaking Medicine Technology:SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 2SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology 3NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 1Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 2Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 3Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 4Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 5Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 6Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 7Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 8Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 9Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 10Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 11Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 12Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 13Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 14Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 15Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 16Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 17Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 18Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 19Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 20Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 21Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 22Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 23Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 24Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 25Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 26Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 27Angiotech Pharmaceuticals Inc announces financial results for the second quarter ended June 30 2009 13411 28Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference 53829 1